Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care — Fort Lauderdale, Florida

Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care is a clinical research site located in Fort Lauderdale, Florida, United States 33312.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease, Coronary Heart Disease (CHD).

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care?

Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care conducted?

Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care has 2 clinical trials on record, with 1 currently active. Their work covers Atherosclerotic Cardiovascular Disease, Coronary Heart Disease (CHD).

Is Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care accredited by Crixeo Health?

Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.